MS, M., TS, S., TC, S., TM, M., FS, D., KP, A., . . . AV, C. (2021). DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-oncology, 23(8), 1292. https://doi.org/10.1093/neuonc/noab044
Chicago Style (17th ed.) CitationMS, Mosella, et al. "DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features." Neuro-oncology 23, no. 8 (2021): 1292. https://doi.org/10.1093/neuonc/noab044.
MLA (9th ed.) CitationMS, Mosella, et al. "DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features." Neuro-oncology, vol. 23, no. 8, 2021, p. 1292, https://doi.org/10.1093/neuonc/noab044.
Warning: These citations may not always be 100% accurate.